XBIO Income Statement (2011-2025) | XBIO

1Y3Y5Y7Y10YAll
Download Data
Income Statement Nov2011 Feb2012 May2012 Aug2012 Nov2012 Feb2013 May2013 Aug2013 Nov2013 Mar2014 Jun2014 Sep2014 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Revenue & cost
Revenue (Quarter) 0.01M0.04M0.04M0.03M0.03M0.04M0.00M-884.00-0.00M0.61M0.65M0.61M0.67M0.51M0.73M0.61M0.65M0.59M0.59M1.03M0.77M
Cost of Revenue (Quarter) 0.00M0.01M0.01M0.01M0.00M0.01M
Gross Profit (Quarter) 0.01M0.03M0.04M0.02M0.03M0.03M
Operating items
Depreciation & Amortization - Total (Quarter) 0.00M0.01M0.02M0.01M0.01M-0.00M0.05M-0.01M
Research & Development (Quarter) 0.57M1.03M1.91M0.60M0.90M1.02M0.98M0.94M0.93M0.37M1.04M0.88M0.66M0.76M0.50M
Selling, General & Administrative (Quarter) 2.43M1.61M1.20M0.93M0.95M0.74M0.95M0.83M1.13M0.75M0.71M0.66M0.66M0.82M0.62M
Other Operating Expenses (Quarter) 0.03M0.05M0.06M0.03M0.02M-0.01M0.08M-1.07M0.27M
Operating Expenses (Quarter) 0.03M0.06M0.07M0.01M0.04M0.01M0.04M-0.01M0.08M2.99M2.64M3.11M1.52M1.85M1.76M1.93M1.78M2.06M1.11M1.75M1.54M1.31M1.57M1.39M
Operating Income (Quarter) -0.01M-0.03M-0.04M-0.01M0.02M-0.01M-0.08M-2.99M-2.64M-3.11M-0.92M-1.20M-1.15M-1.26M-1.27M-1.34M-0.50M-1.10M-0.94M-0.72M-0.54M-0.62M
EBIT (Quarter) -0.01M-0.03M-0.04M-0.01M0.02M-0.01M-0.08M-2.99M-2.64M-3.11M-0.92M-1.20M-1.15M-1.26M-1.27M-1.34M-0.50M-1.10M-0.94M-0.72M-0.54M-0.62M
Non-operating items
Interest & Investment Income (Quarter) 0.00M0.01M218.00
Other Non Operating Income (Quarter) -1.07M-0.13M-0.07M0.00M0.02M-666.00404.0052.00-21.000.00M-0.01M78.000.00M0.00M159.00
Non Operating Income (Quarter) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.01M-1.07M-0.12M-0.07M0.06M0.15M-666.00-0.27M0.07M-21.000.00M0.24M0.04M0.00M0.00M0.04M
Net income details
EBT (Quarter) -0.01M-0.02M-0.03M-0.01M0.02M-0.01M-0.07M-4.06M-2.76M-3.18M-0.92M-1.20M-1.15M-1.26M-1.27M-1.34M-0.50M-1.10M-0.94M-0.72M-0.54M-0.62M
Profit After Tax (Quarter) -0.02M-0.03M-0.04M-0.01M0.02M-0.01M-0.08M-4.06M-2.76M-3.18M-0.86M-1.05M-1.06M-1.17M-1.20M-1.27M-0.44M-1.05M-0.90M-0.69M-0.51M-0.58M
Income from Continuing Operations (Quarter) -0.01M-0.02M-0.03M-0.01M0.02M-0.01M-0.07M-4.06M-2.76M-3.18M-0.92M-1.20M-1.15M-1.26M-1.27M-1.34M-0.50M-1.10M-0.94M-0.72M-0.54M-0.62M
Consolidated Net Income (Quarter) -0.01M-0.02M-0.03M-0.01M0.02M-0.01M-0.07M-4.06M-2.76M-3.18M-0.92M-1.20M-1.15M-1.26M-1.27M-1.34M-0.50M-1.10M-0.94M-0.72M-0.54M-0.62M
Income towards Parent Company (Quarter) -0.01M-0.02M-0.03M-0.01M0.02M-0.01M-0.07M-4.06M-2.76M-3.18M-0.92M-1.20M-1.15M-1.26M-1.27M-1.34M-0.50M-1.10M-0.94M-0.72M-0.54M-0.62M
Net Income towards Common Stockholders (Quarter) -0.01M-0.02M-0.03M-0.01M0.02M-0.01M-0.07M-4.06M-2.76M-3.18M-0.92M-1.20M-1.15M-1.26M-1.27M-1.34M-0.50M-1.10M-0.94M-0.72M-0.54M-0.62M
Additional items
EPS (Basic) (Quarter) 0.000.000.000.000.000.000.00-0.03-0.02-0.02-114.40-0.79-0.69-0.77-0.78-0.83-0.28-0.68-0.59-0.45-0.33-0.22
EPS (Weighted Average and Diluted) (Quarter) -0.60-0.79-0.69-0.77-0.78-0.83-0.28-0.68-0.59-0.45-0.33-0.22
Shares Outstanding (Weighted Average) (Quarter) 10.00M100.00M107.15M144.15M13.50M135.00M135.00M135.00M135.00M136.05M134.09M136.05M0.01M1.52M0.00M0.00M0.00M1.54M0.46M1.54M800.001.54M1.54M1.70M
Shares Outstanding (Diluted Average) (Quarter) 1.52M1.52M1.53M1.53M1.54M1.54M1.54M1.54M1.54M1.54M1.54M1.70M
EBITDA (Quarter) -0.01M-0.02M-0.02M718.000.02M0.04M-0.08M-3.94M-2.36M-3.72M-0.92M-1.20M-1.15M-1.26M-1.27M-1.34M-0.50M-1.10M-0.94M-0.72M-0.54M-0.62M
Interest Expenses (Quarter) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.01M884.000.00M0.00M